S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

NASDAQ:PAHC - Phibro Animal Health Stock Price, Forecast & News

$27.02
-0.04 (-0.15 %)
(As of 02/18/2020 04:00 PM ET)
Today's Range
$26.77
Now: $27.02
$27.38
50-Day Range
$23.72
MA: $25.74
$27.72
52-Week Range
$20.00
Now: $27.02
$36.98
Volume272,000 shs
Average Volume140,569 shs
Market Capitalization$1.09 billion
P/E Ratio28.74
Dividend Yield1.77%
Beta0.78
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.23 per share
Book Value$5.34 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$1.09 billion
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, February 3rd. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.12 per share on Wednesday, March 25th. This represents a $0.48 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Tuesday, March 3rd. View Phibro Animal Health's Dividend History.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) released its quarterly earnings results on Monday, February, 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.06. The business had revenue of $214 million for the quarter, compared to analyst estimates of $218.87 million. Phibro Animal Health had a return on equity of 23.94% and a net margin of 4.67%. The firm's revenue for the quarter was down 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.41 earnings per share. View Phibro Animal Health's Earnings History.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Phibro Animal Health.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY20 earnings guidance on Monday, February, 3rd. The company provided earnings per share guidance of $1.15-1.22 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11. The company issued revenue guidance of $812-828 million, compared to the consensus revenue estimate of $838.36 million.

What price target have analysts set for PAHC?

6 brokers have issued 1-year price targets for Phibro Animal Health's stock. Their forecasts range from $18.00 to $30.00. On average, they expect Phibro Animal Health's stock price to reach $25.20 in the next twelve months. This suggests that the stock has a possible downside of 6.7%. View Analyst Price Targets for Phibro Animal Health.

What is the consensus analysts' recommendation for Phibro Animal Health?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating and 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

News headlines about PAHC stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Phibro Animal Health earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Phibro Animal Health.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Banco Bradesco (BBD) and Gilead Sciences (GILD).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the folowing people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (2.68%), Principal Financial Group Inc. (2.35%), Renaissance Technologies LLC (2.07%), State Street Corp (1.71%), Cove Street Capital LLC (1.47%) and Eagle Asset Management Inc. (1.16%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran and Jack Bendheim. View Institutional Ownership Trends for Phibro Animal Health.

Which major investors are selling Phibro Animal Health stock?

PAHC stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Ceredex Value Advisors LLC, Acadian Asset Management LLC, Oxford Asset Management LLP, Bank of New York Mellon Corp, Goldman Sachs Group Inc., AQR Capital Management LLC and Credit Suisse AG. View Insider Buying and Selling for Phibro Animal Health.

Which major investors are buying Phibro Animal Health stock?

PAHC stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Eagle Asset Management Inc., Madison Asset Management LLC, Heartland Advisors Inc., Martingale Asset Management L P, Raymond James & Associates, Renaissance Technologies LLC and South Dakota Investment Council. View Insider Buying and Selling for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $27.02.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $1.09 billion and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  276 (Vote Outperform)
Underperform Votes:  342 (Vote Underperform)
Total Votes:  618
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel